Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in co...
Gespeichert in:
| Veröffentlicht in: | Journal of child and adolescent psychopharmacology 2005-12, Vol.15 (6), p.996-1004 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1004 |
|---|---|
| container_issue | 6 |
| container_start_page | 996 |
| container_title | Journal of child and adolescent psychopharmacology |
| container_volume | 15 |
| creator | Hah, Mina Chang, Kiki |
| description | Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD. |
| doi_str_mv | 10.1089/cap.2005.15.996 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_204605103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>987983161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c322t-7e8caade35ede293fe518f74bb0318a4aa4a9e367eb1bf90352226ac993393293</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotlbP3iR43zYfm93NsRS_oOBFzyGbzNKUdrMmqVrwx5vSojAwc3ifd-BB6JaSKSWNnBk9TBkhYkrFVMrqDI2pEHXRSMnO803KshBlxUfoKsY1IZRXpLpEI1rxWgpGxuhnnvzWf0NyPeDOB5xWgFMAnbbQJ-w7rFPKl_N9YaFzxqXZaj9A0Ca5T5f22Lrog4WAXY_Nym1sgB7r3mJt_QaiyXDEXy6tcOsGv9Hhj4jX6KLTmwg3pz1B748Pb4vnYvn69LKYLwvDGUtFDY3R2gIXYIFJ3oGgTVeXbUs4bXSp80jgVQ0tbTtJuGCMVdpIybnkGZig-2PvEPzHDmJSa78LfX6pGCkrIijhOTQ7hkzwMQbo1BDcVoe9okQdZKssWx1kKypUlp2Ju1Ptrt2C_c-f7PJf9ml-BA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204605103</pqid></control><display><type>article</type><title>Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Hah, Mina ; Chang, Kiki</creator><creatorcontrib>Hah, Mina ; Chang, Kiki</creatorcontrib><description>Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.</description><identifier>ISSN: 1044-5463</identifier><identifier>EISSN: 1557-8992</identifier><identifier>DOI: 10.1089/cap.2005.15.996</identifier><identifier>PMID: 16379520</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adolescent ; Antimanic Agents - adverse effects ; Antimanic Agents - therapeutic use ; Atomoxetine Hydrochloride ; Attention Deficit Disorder with Hyperactivity - diagnosis ; Attention Deficit Disorder with Hyperactivity - drug therapy ; Attention deficit hyperactivity disorder ; Bipolar disorder ; Bipolar Disorder - diagnosis ; Bipolar Disorder - drug therapy ; Case studies ; Children & youth ; Comorbidity ; Drug Therapy, Combination ; Humans ; Male ; Medical treatment ; Prescription drugs ; Propylamines - adverse effects ; Propylamines - therapeutic use ; Retrospective Studies ; Teenagers ; Treatment Outcome</subject><ispartof>Journal of child and adolescent psychopharmacology, 2005-12, Vol.15 (6), p.996-1004</ispartof><rights>(©) Copyright 2005, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c322t-7e8caade35ede293fe518f74bb0318a4aa4a9e367eb1bf90352226ac993393293</citedby><cites>FETCH-LOGICAL-c322t-7e8caade35ede293fe518f74bb0318a4aa4a9e367eb1bf90352226ac993393293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16379520$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hah, Mina</creatorcontrib><creatorcontrib>Chang, Kiki</creatorcontrib><title>Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders</title><title>Journal of child and adolescent psychopharmacology</title><addtitle>J Child Adolesc Psychopharmacol</addtitle><description>Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.</description><subject>Adolescent</subject><subject>Antimanic Agents - adverse effects</subject><subject>Antimanic Agents - therapeutic use</subject><subject>Atomoxetine Hydrochloride</subject><subject>Attention Deficit Disorder with Hyperactivity - diagnosis</subject><subject>Attention Deficit Disorder with Hyperactivity - drug therapy</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Bipolar disorder</subject><subject>Bipolar Disorder - diagnosis</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Case studies</subject><subject>Children & youth</subject><subject>Comorbidity</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Prescription drugs</subject><subject>Propylamines - adverse effects</subject><subject>Propylamines - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Teenagers</subject><subject>Treatment Outcome</subject><issn>1044-5463</issn><issn>1557-8992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpFkE1LAzEQhoMotlbP3iR43zYfm93NsRS_oOBFzyGbzNKUdrMmqVrwx5vSojAwc3ifd-BB6JaSKSWNnBk9TBkhYkrFVMrqDI2pEHXRSMnO803KshBlxUfoKsY1IZRXpLpEI1rxWgpGxuhnnvzWf0NyPeDOB5xWgFMAnbbQJ-w7rFPKl_N9YaFzxqXZaj9A0Ca5T5f22Lrog4WAXY_Nym1sgB7r3mJt_QaiyXDEXy6tcOsGv9Hhj4jX6KLTmwg3pz1B748Pb4vnYvn69LKYLwvDGUtFDY3R2gIXYIFJ3oGgTVeXbUs4bXSp80jgVQ0tbTtJuGCMVdpIybnkGZig-2PvEPzHDmJSa78LfX6pGCkrIijhOTQ7hkzwMQbo1BDcVoe9okQdZKssWx1kKypUlp2Ju1Ptrt2C_c-f7PJf9ml-BA</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Hah, Mina</creator><creator>Chang, Kiki</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>200512</creationdate><title>Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders</title><author>Hah, Mina ; Chang, Kiki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c322t-7e8caade35ede293fe518f74bb0318a4aa4a9e367eb1bf90352226ac993393293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Antimanic Agents - adverse effects</topic><topic>Antimanic Agents - therapeutic use</topic><topic>Atomoxetine Hydrochloride</topic><topic>Attention Deficit Disorder with Hyperactivity - diagnosis</topic><topic>Attention Deficit Disorder with Hyperactivity - drug therapy</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Bipolar disorder</topic><topic>Bipolar Disorder - diagnosis</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Case studies</topic><topic>Children & youth</topic><topic>Comorbidity</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Prescription drugs</topic><topic>Propylamines - adverse effects</topic><topic>Propylamines - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Teenagers</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hah, Mina</creatorcontrib><creatorcontrib>Chang, Kiki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of child and adolescent psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hah, Mina</au><au>Chang, Kiki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders</atitle><jtitle>Journal of child and adolescent psychopharmacology</jtitle><addtitle>J Child Adolesc Psychopharmacol</addtitle><date>2005-12</date><risdate>2005</risdate><volume>15</volume><issue>6</issue><spage>996</spage><epage>1004</epage><pages>996-1004</pages><issn>1044-5463</issn><eissn>1557-8992</eissn><abstract>Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>16379520</pmid><doi>10.1089/cap.2005.15.996</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1044-5463 |
| ispartof | Journal of child and adolescent psychopharmacology, 2005-12, Vol.15 (6), p.996-1004 |
| issn | 1044-5463 1557-8992 |
| language | eng |
| recordid | cdi_proquest_journals_204605103 |
| source | Mary Ann Liebert Online Subscription; MEDLINE |
| subjects | Adolescent Antimanic Agents - adverse effects Antimanic Agents - therapeutic use Atomoxetine Hydrochloride Attention Deficit Disorder with Hyperactivity - diagnosis Attention Deficit Disorder with Hyperactivity - drug therapy Attention deficit hyperactivity disorder Bipolar disorder Bipolar Disorder - diagnosis Bipolar Disorder - drug therapy Case studies Children & youth Comorbidity Drug Therapy, Combination Humans Male Medical treatment Prescription drugs Propylamines - adverse effects Propylamines - therapeutic use Retrospective Studies Teenagers Treatment Outcome |
| title | Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A36%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atomoxetine%20for%20the%20treatment%20of%20attention-deficit/hyperactivity%20disorder%20in%20children%20and%20adolescents%20with%20bipolar%20disorders&rft.jtitle=Journal%20of%20child%20and%20adolescent%20psychopharmacology&rft.au=Hah,%20Mina&rft.date=2005-12&rft.volume=15&rft.issue=6&rft.spage=996&rft.epage=1004&rft.pages=996-1004&rft.issn=1044-5463&rft.eissn=1557-8992&rft_id=info:doi/10.1089/cap.2005.15.996&rft_dat=%3Cproquest_cross%3E987983161%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204605103&rft_id=info:pmid/16379520&rfr_iscdi=true |